Analysis of Swallowing Functional Preservation by Surgical Versus CRT After Induction Chemotherapy for Oropharyngeal Cancer
- PMID: 39518095
- PMCID: PMC11545259
- DOI: 10.3390/cancers16213658
Analysis of Swallowing Functional Preservation by Surgical Versus CRT After Induction Chemotherapy for Oropharyngeal Cancer
Abstract
Objectives: This retrospective observational study investigated to determine whether surgery or chemoradiation therapy after induction chemotherapy leads to better swallow function for oropharyngeal cancer patients. Methods: We documented the treatment paths and results of 267 patients with oropharyngeal squamous cell cancer (OPSCC). By quantifying nasogastric (NG) tube usage, surgery after induction chemotherapy (IC-surgery), and chemoradiation therapy after induction chemotherapy (IC-CRT) could be compared to determine the effectiveness of each. Cancer stages were also recorded concerning treatment options. The differences in NG tube usage IC-surgery and IC-CRT groups were compared. The NG tube dependence rates were also presented. Results: The prognosis and tube dependence differed significantly between the two groups. The IC-surgery had a better prognosis compared to IC-CRT for oropharyngeal cancer. The findings indicated that NG tube dependence was greater in advanced tumor stage 4 compared to stages 1-3, and NG tube dependence rates were higher for patients who underwent chemoradiation therapy after induction chemotherapy. Swallowing function was better in the IC-surgery group compared to the IC-CRT group. Conclusions: Higher NG tube retention rates and NG dependence are found in OPSCC patients who choose CRT as their treatment and also in the advanced-stage group.
Keywords: chemoradiation; dysphagia; nasogastric tube; oropharyngeal squamous cell cancer; surgery.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.JAMA Otolaryngol Head Neck Surg. 2023 Nov 1;149(11):980-986. doi: 10.1001/jamaoto.2023.1944. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 37422846 Free PMC article.
-
Predictors of gastrostomy tube dependence in surgically managed oropharyngeal squamous cell carcinoma.Laryngoscope. 2019 Feb;129(2):415-421. doi: 10.1002/lary.27290. Epub 2018 Sep 8. Laryngoscope. 2019. PMID: 30194767 Free PMC article.
-
Comparative effectiveness of induction chemotherapy for oropharyngeal squamous cell carcinoma: A population-based analysis.Oral Oncol. 2016 Mar;54:58-67. doi: 10.1016/j.oraloncology.2015.12.008. Epub 2016 Jan 18. Oral Oncol. 2016. PMID: 26794877
-
Transoral robotic surgery for oropharyngeal cancer in the era of chemoradiation therapy.Auris Nasus Larynx. 2022 Aug;49(4):535-546. doi: 10.1016/j.anl.2022.01.011. Epub 2022 Jan 31. Auris Nasus Larynx. 2022. PMID: 35101284 Review.
-
Meta-analysis of induction chemotherapy as a selection marker for chemoradiation in the head and neck.Laryngoscope. 2018 Jul;128(7):1594-1601. doi: 10.1002/lary.27011. Epub 2017 Nov 24. Laryngoscope. 2018. PMID: 29171671
Cited by
-
Surgery Versus Chemoradiation Therapy for Oropharyngeal Squamous Cell Carcinoma: A Multidimensional Cross-Sectional Study.Diseases. 2025 Apr 2;13(4):106. doi: 10.3390/diseases13040106. Diseases. 2025. PMID: 40277817 Free PMC article.
References
-
- Herrero R., Castellsagué X., Pawlita M., Lissowska J., Kee F., Balaram P., Rajkumar T., Sridhar H., Rose B., Pintos J., et al. Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study. J. Natl. Cancer Inst. 2003;95:1772–1783. doi: 10.1093/jnci/djg107. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials